12.04.24 -- How To Lead a Company That's Disrupting An Industry

Clinical trials often face unforeseen challenges that can derail progress and necessitate costly corrective efforts. However, many of these challenges can be avoided with proactive planning and early intervention. Explore the most critical steps companies can take to prevent trials from reaching a point of crisis and the importance of addressing systemic issues before they escalate. Click here to learn more.

Global vaccine maker, CSL Seqirus, has received federal grants totaling $155.4 million to expand production of an avian influenza vaccine. Read more about this pandemic-preparedness initiative.

As the European Medicines Agency (EMA) finalizes its reflection paper on real-world evidence (RWE), the growing importance of this data source for regulatory decision-making becomes increasingly evident.

Explore how understanding patient and caregiver experiences, along with implementing effective patient support strategies, can reduce barriers, enhance retention, and improve outcomes.

By using an optimized transient transfection platform, drug developers can accelerate their characterization and early development activities, facilitating continuity for a drug's scale-up.

Learn how leveraging the expertise and capabilities of an experienced partner is a key factor in optimizing AAV processes using Design of Experiment (DoE), thereby reducing variability and risk.

Learn to modernize and streamline the technology solutions that empower client service, research study and project management, and overall operational efficiency.